Lite Strategy LITS
NASDAQ LITS
$1.06 +0.00 (+0.00%)
At close: Sep 10, 2026 · 4:00 PM EDT

Lite Strategy (LITS) Capital Expenditures (2010 - 2025)

Lite Strategy (LITS) posted Capital Expenditures of $100.0 million for Q3 2025, up 1428471.43% on a QoQ basis from $7000.0 in Q3 2023.

Analysis

Lite Strategy (LITS) Capital Expenditures (2010 - 2025) Analysis & Trends

Lite Strategy has reported Capital Expenditures for 13 years, with the latest figure at $100.0 million in Q3 2025.

  • On a quarterly basis, Capital Expenditures changed N/A year-over-year to $100.0 million in Q3 2025; TTM through Mar 2026 was $100.0 million, a N/A change from a year earlier, with the FY2024 full-year figure at $7000.0, down 80.0% from the prior year.
  • Capital Expenditures was $100.0 million for Q3 2025 at Lite Strategy, up from $7000.0 in the prior quarter.
  • The five-year high for Capital Expenditures was $100.0 million in Q3 2025, with the low at -$63000.0 in Q4 2022.
  • Average Capital Expenditures over 4 years is $10.1 million, with a median of $43000.0 recorded in 2021.
  • The largest YoY upside for Capital Expenditures was 3725.0% in 2022 against a maximum downside of 223.53% in 2022.
  • Over 4 years, Capital Expenditures stood at $51000.0 in 2021, then tumbled by 223.53% to -$63000.0 in 2022, then soared by 111.11% to $7000.0 in 2023, then soared by 1428471.43% to $100.0 million in 2025.
  • The last three Capital Expenditures figures came in at $100.0 million (Q3 2025), $7000.0 (Q3 2023), and $35000.0 (Q2 2023), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Capital Expenditures (Qtr)
1 Amgen 206.44 Bn 192.45 Bn 7.24 Bn 513.00 Mn
2 Gilead Sciences 179.97 Bn 176.79 Bn 6.22 Bn 140.00 Mn
3 Vertex Pharmaceuticals 130.57 Bn 122.72 Bn 2.84 Bn 112.20 Mn
4 Regeneron Pharmaceuticals 81.63 Bn 73.63 Bn 3.93 Bn 240.20 Mn
5 Argenx Se 60.34 Bn 55.16 Bn 1.37 Bn -
6 Moderna 54.37 Bn 49.23 Bn 52.00 Mn 37.00 Mn
7 Alnylam Pharmaceuticals 33.07 Bn 29.76 Bn 992.69 Mn 34.68 Mn
8 Biogen 31.84 Bn 30.55 Bn 1.96 Bn 40.90 Mn
9 Roivant Sciences 29.49 Bn 29.49 Bn 1.16 Mn -1.87 Mn
10 Lite Strategy 38.03 Mn 30.49 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2025 100.00 Mn
Sep 30, 2023 7,000.00
Jun 30, 2023 35,000.00
Dec 31, 2022 -63,000.00
Sep 30, 2022 63,000.00
Jun 30, 2022 306,000.00
Mar 31, 2022 114,000.00
Dec 31, 2021 51,000.00
Sep 30, 2021 8,000.00
Jun 30, 2021 8,000.00
Dec 31, 2020 56,000.00
Sep 30, 2020 644,000.00
Jun 30, 2020 109,000.00
Mar 31, 2020 780,000.00
Jun 30, 2019 10,000.00
Mar 31, 2019 35,000.00
Jun 30, 2017 49,000.00
Sep 30, 2016 2,000.00
Jun 30, 2016 1,000.00
Jun 30, 2015 -1,000.00